| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.69▲ | 4.65▲ | 4.63▲ | 4.48▲ | 5.66▼ |
| MA10 | 4.65▲ | 4.60▲ | 4.43▲ | 5.30▼ | 6.39▼ |
| MA20 | 4.65▲ | 4.40▲ | 4.37▲ | 5.77▼ | 6.43▼ |
| MA50 | 4.59▲ | 4.40▲ | 4.88▼ | 6.51▼ | 6.96▼ |
| MA100 | 4.37▲ | 5.03▼ | 5.52▼ | 6.48▼ | 7.97▼ |
| MA200 | 4.42▲ | 5.57▼ | 6.21▼ | 6.90▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.045▲ | 0.100▲ | -0.173▼ | -0.194▼ |
| RSI | 71.567▲ | 68.951▲ | 58.746▲ | 38.354▼ | 34.695▼ |
| STOCH | 63.425 | 87.747▲ | 94.048▲ | 9.189▼ | 25.004 |
| WILL %R | -11.429▲ | -2.564▲ | -2.532▲ | -75.484▼ | -79.652▼ |
| CCI | 205.714▲ | 105.479▲ | 115.911▲ | -81.555 | -229.241▼ |
|
Thursday, November 05, 2026 08:07 AM
In April 2026, Gyre Pharmaceuticals initiated its adaptive Phase 2/3 clinical trial in oncology-related pulmonary complications, with the first patient enrolled. The trial is evaluating pirfenidone ...
|
|
Wednesday, October 15, 2025 04:00 AM
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Gyre ...
|
|
Thursday, October 09, 2025 05:00 PM
As of September 30, 2025, the average one-year price target for Gyre Therapeutics is $19.38/share. The forecasts range from a low of $18.18 to a high of $21.00. The average price target represents an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 4.56 | 4.79 | 4.08 | 4.76 | 359,700 |
| 05/11/26 | 4.50 | 4.50 | 4.00 | 4.01 | 266,440 |
| 04/11/26 | 4.57 | 4.65 | 4.33 | 4.44 | 256,353 |
| 03/11/26 | 4.61 | 4.7133 | 4.40 | 4.44 | 239,505 |
| 02/11/26 | 4.78 | 5.1108 | 4.265 | 4.73 | 389,772 |
| 30/10/26 | 6.27 | 6.30 | 4.515 | 4.555 | 393,771 |
| 29/10/26 | 6.86 | 6.985 | 6.37 | 6.41 | 185,320 |
| 28/10/26 | 6.53 | 7.10 | 6.33 | 7.09 | 125,144 |
| 27/10/26 | 6.10 | 6.55 | 6.01 | 6.53 | 126,372 |
| 26/10/26 | 5.77 | 6.0995 | 5.77 | 6.07 | 93,373 |
|
|
||||
|
|
||||
|
|